Cargando…
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(®) therapy: A case report
Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir(®) as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression‐free survival are good.
Autores principales: | Pumpure, Elizabete, Dručka, Eva, Kigitoviča, Dana, Meškauskas, Raimundas, Isajevs, Sergejs, Nemiro, Ineta, Rasa, Agnija, Olmane, Evija, Zablocka, Tatjana, Alberts, Pēteris, Doniņa, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455402/ https://www.ncbi.nlm.nih.gov/pubmed/32884791 http://dx.doi.org/10.1002/ccr3.2928 |
Ejemplares similares
-
Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir
por: Proboka, Guna, et al.
Publicado: (2020) -
Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir: A retrospective case report
por: Proboka, Guna, et al.
Publicado: (2019) -
A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report
por: Sorokins, Vladimirs, et al.
Publicado: (2020) -
Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report
por: Proboka, Guna, et al.
Publicado: (2018) -
Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery
por: Tilgase, Andra, et al.
Publicado: (2018)